Stone House Investment Management’s Medtronic MDT Stock Holding History

Stone House Investment Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.46K	Sell	63 -11	-15%	-$1.05K	﹤0.01%	446
2025 Q4	$7.11K	Buy	74 +3	+4%	+$291	﹤0.01%	364
2025 Q3	$6.76K	Buy	71 +11	+18%	+$1.01K	﹤0.01%	330
2025 Q2	$5.23K	Hold	60	–	–	﹤0.01%	320
2025 Q1	$5.39K	Buy	+60	New	+$5.37K	﹤0.01%	305
2024 Q4	–	Sell	-60	Closed	-$5.4K	–	226
2024 Q3	$5.4K	Hold	60	–	–	﹤0.01%	266
2024 Q2	$4.72K	Hold	60	–	–	﹤0.01%	278
2024 Q1	$5.23K	Hold	60	–	–	﹤0.01%	285
2023 Q4	$4.94K	Sell	60 -193	-76%	-$14.7K	﹤0.01%	208
2023 Q3	$19.8K	Buy	253 +1	+0.4%	+$84	0.01%	120
2023 Q2	$22.2K	Buy	252 +200	+385%	+$17.2K	0.01%	112
2023 Q1	$4.18K	Buy	+52	New	+$4.24K	﹤0.01%	211

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stone House Investment Management's MDT Position: Q1 2026 in Review

Stone House Investment Management reduced its Medtronic (MDT) stake by 15% in Q1 2026, selling an estimated $1.05K and leaving 63 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Stone House Investment Management first reported a position in MDT in Q1 2023 and has held it in 12 quarters since. The position peaked at $22.2K in Q2 2023. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Stone House Investment Management held 63 shares of Medtronic worth $5.46K as of Q1 2026.
Stone House Investment Management sold 11 Medtronic shares in Q1 2026, an estimated $1.05K.
Medtronic made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #446 holding.
Stone House Investment Management first reported a position in Medtronic in Q1 2023 and has held it in 12 quarters since.
Stone House Investment Management's Medtronic position peaked at $22.2K in Q2 2023.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.